
follow us
disclaim warranti liabil
due number sourc inform servic acquisdata pti ltd servic obtain
inher hazard electron distribut may delay omiss inaccuraci inform
servic acquisdata pti ltd affili agent sale repres distributor licensor
warrant accuraci complet current merchant abil fit particular purpos
inform servic avail acquisdata pti ltd servic event acquisdata pti ltd
affili agent sale repres distributor licensor liabl license anyon els loss
injuri caus whole part conting beyond control procur compil interpret edit write
report deliv inform servic acquisdata pti ltd servic event acquisdata
pti ltd affili agent sale repres distributor licensor liabl license anyon els
decis made action taken license relianc upon inform servic consequenti
special similar damag even advis possibl damag license agre liabil
acquisdata pti ltd affili agent sale repres distributor licensor aris kind
legal claim whether contract tort otherwis way connect acquisdata pti ltd servic shall
exceed amount license paid use acquisdata pti ltd servic twelv month immedi
preced event give rise claim
today report earn second quarter updat full-year earn outlook
momentum second quarter reflect on-going impact baxter innov coupl emphasi
oper excel deliv commit potenti said jo almeida chairman chief
execut offic well posit captur new growth opportun emerg acceler
perform drive increas valu patient healthcar provid investor
world-wide sale second quarter total approxim billion compar second quarter
perform report basi increas constant currenc oper basi
oper sale second quarter exclud impact foreign exchang gener competit
sale total billion decreas report oper basi sale
billion increas report basi constant currenc basi region basi sale
america flat report basi increas constant currenc basi sale europ middl east
africa emea decreas report advanc constant currenc basi asia pacif
apac report sale constant currenc sale increas respect
growth driver second quarter includ baxter periton dialysi pd continu renal replac
therapi crrt intraven iv infus system hemostat sealant certain gener pharmaceut
addit increas demand baxter hospit pharmaci compound contribut growth quarter
sale growth partial off-set expect lower sale brevibloc cyclophosphamid well in-
center hemodialysi ichd product due increas competit exit bloodlin busi
pleas see attach schedul accompani press releas addit detail sale perform
quarter includ breakout baxter three geograph segment six global busi unit
baxter report net incom million per dilut share gener accept account
principl basi second quarter result includ special item total million tax
primarili relat intang asset amort intang asset impair busi optim initi
adjust basi baxter second quarter net incom total million per dilut share earn
growth quarter driven solid oper perform benefit lower tax rate share
count compar prior year period
juli white hous announc advanc american kidney health initi groundbreak
propos focus improv outcom lower health system cost offer quality-of-lif benefit
patient chronic kidney diseas ckd ckd impact live million american
end stage renal diseas esrd kidney failur requir dialysi treatment organ
transplant surviv propos initi aim increas number new esrd patient receiv
home dialysi organ transplant baxter commit help drive home dialysi
adopt line goal
depend initi final form baxter plan scale invest align propos
model center medicar medicaid servic patient market dynam across
adopt curv invest current anticip million potenti new facil well
exist site make distribut pd solut devic cassett expect creat hundr
high-qual manufactur suppli chain engin job american compani anticip
invest help acceler renal growth contribut posit baxter previou financi
stand readi help administr healthcar provid improv care american battl end
stage renal diseas said almeida lead innov provid home pd therapi
world-wide excit expand patient access mani benefit pd look forward mobil
support initi final paramet take shape month ahead
baxter continu achiev key mileston pursuit mission patient emphasi acceler
profit growth among recent highlight compani
announc food drug administr fda approv myxredlin insulin human sodium
chlorid inject first ready-to-us insulin iv infus hospit acut care
set util baxter proprietari galaxi contain technolog myxredlin offer extend shelf life
deliv consist stabl concentr everi administr key consider patient safeti
launch sharesourc clinic portal give healthcar provid greater insight patient home
pd treatment offer improv clinic workflow sharesourc wide adopt telehealth platform
global help manag million pd treatment countri grow
evid remot patient manag technolog assist healthcar provid earli detect
cathet issu periton adherence-rel complic lead reduc hospit
announc new research oxiri filter use simultan crrt remov
cytokin endotoxin aid manag acut kidney injuri aki patient sepsi research
publish supplement issu peer-review journal blood purif highlight
vicenza cours aki crrt held vicenza itali may
showcas data present across renal care continuum era-edta congress held june
budapest hungari among five independ studi hdx expand hemodialysi use
theranova dialyz advanc grow evid therapi extend rang molecul
filter blood hdx result clearanc profil close mimic natur kidney
full-year compani expect sale growth report basi approxim
constant currenc oper basi baxter expect earn continu oper
per share adjust earn continu oper special item
third-quart compani expect sale growth report basi grow
approxim constant currenc oper basi baxter expect earn continu
oper per share adjust earn continu oper special item
per dilut share
full-year quarterli oper sale estim adjust impact foreign exchang
gener competit cyclophosphamid
acquisdata proud host leagu estim want opportun win free
subscript join acquisdata media telecommun leagu
baxter touch million live everi day product servic essenti build block healthcar
youll find baxter product therapi nearli everi floor everi depart almost everi hospit
world-wide youll find us clinic home
acquisdata date busi intellig report cover develop world
report vast archiv corpor document list compani around world
abbott global diversifi healthcar compani central purpos help peopl live healthiest possibl
live offer broad portfolio market-lead product align favor long-term healthcar trend
develop develop market build strong foundat year success abbott
pois deliv top-tier growth expand margin strong cash flow increas return sharehold
januari found global biopharmaceut compani focu capabl
address world greatest health challeng stabil resourc expertis passion
discov develop bring market groundbreak scienc solv biggest health problem face
world today tomorrow
one world lead biotechnolog compani values-bas compani deepli root
scienc innov transform new idea discoveri medicin patient seriou ill
commit unlock potenti biolog patient suffer seriou ill discov
develop manufactur deliv innov human therapeut approach begin use tool like
advanc human genet unravel complex diseas understand fundament human biolog
bausch health compani inc formerli valeant pharmaceut multi-national specialti pharmaceut
compani base laval canada bausch health focus improv peopl live health care
product deliv commit patient health care provid stakehold societi
build innov compani dedic advanc global health
manufactur market broad rang brand gener pharmaceut over-the-count over-the-counter
product medic devic contact lens intraocular lens ophthalm surgic equip aesthet
devic directli indirectli countri region includ unit state canada europ
middl east africa asia pacif latin america day product use million peopl
around world
bristol-my squibb global biopharma compani firmli focus mission discov develop deliv
innov medicin help patient prevail seriou diseas bristol-my squibb uk aim deliv
commit patient custom employe commun environ
 compani found colonel eli lilli man commit creat high-qual medicin
meet real need centuri later passion build preced continu
pursuit make life better individu commun world around us
found year ago genentech lead biotechnolog compani discov develop
manufactur commerci medicin treat patient seriou life-threaten medic condit
compani member roch group headquart south san francisco california
johnson johnson famili compani engag research develop manufactur
sale broad rang product health care field virtual countri world johnson johnson
primari interest histor current product relat human health well-b
johnson johnson incorpor state new jersey
base unit state distribut health care system medic suppli pharmaceut
product also provid specialti pharmaceut solut biotech pharmaceut manufactur well
practic manag technolog clinic support oncolog specialti practic addit
deliv comprehens offer healthcar product technolog equip relat servic non-
hospit market includ physician offic surgeri center long-term care facil home healthcar
merck compani inc american pharmaceut compani one largest pharmaceut compani
world compani establish unit state subsidiari german compani merck
found merck famili global healthcar compani histori work
make differ compani known merck unit state canada everywher els known
msd base kenilworth oper countri
novarti intern ag swiss multi-national pharmaceut compani base basel switzerland novarti
creat merger ciba-geigi sandoz novarti predecessor compani trace
root back year rich histori develop innov product novarti manufactur
lamisil other
novo nordisk global healthcar compani year innov leadership diabet care
compani aim provid medic treat wide rang diseas obes haemophilia growth
disord seriou chronic diseas base denmark novo nordisk employ approxim
peopl countri market product countri
open first manufactur facil michigan sign first larg private-label
custom pave way convers re-packag home remedi manufactur
afford health care product shift strateg direct drove growth next sever
decad becam foundat compani mission today perrigo world largest manufactur
over-the-counter healthcar product supplier infant formula store brand market compani also lead
provid brand over-the-counter product throughout europ well lead produc extend
topic prescript drug headquart ireland sell product primarili north america
europ well market includ australia israel china
cousin charl pfizer charl erhart found charl pfizer compani red brick build
brooklyn ny one world largest pharmaceut compani list new york stock
exchang share compon jone industri averag sinc leader
american chemic busi mark anniversari portfolio includ wide array industri
pharmacolog product anchor citric acid camphor cream tartar borax iodin compani
offic new york chicago contact import-export busi crisscross world
regeneron pharmaceut inc lead scienc technolog compani deliv life-
transform medicin seriou diseas inc compani headquart eastview
near tarrytown new york found physician-scientist year ago science-driven approach result
six fda-approv medicin numer product candid rang diseas includ asthma pain
cancer infecti diseas
sanofi french multi-national pharmaceut compani headquart pari franc world
fifth-largest prescript sale sanofi employe repres nation
oncolog thrombosi vaccin world largest produc latter subsidiari sanofi
teva establish global headquart base israel today portfolio
molecul produc approxim billion tablet capsul year manufactur facil
rank among lead pharmaceut compani world activ countri approxim
employe around world dedic mission
biopharmaceut compani across america peopl go work everi day mission help patient
stand hope treatment cure make differ million patient live
commit ensur access patient medicin need preserv strong
economi vibrant research valuabl job also stand behind medicin creat valu
provid patient across health care system
new era medicin breakthrough scienc person therapi transform way
treat patient invest half trillion dollar last decad invest
begin pay progress see today revolution way treat diseas
medicin develop global impact patient across drug develop pipelin percent
potenti firstinclass treatment
innov medicin keep patient healthi hospit reduc need costli medic care
medicin best bet tackl biggest cost driverchron diseasewhich account percent health
invest biopharmaceut innov drive contribut american economi solidifi
america role leader medic innov biopharmaceut compani invest billion
 industri also support million job across countri employe go
work everi day creat new treatment cure patient
support patient access
chang insur design includ grow use deduct coinsur prescript medicin
creat afford challeng mani patient patient enrol high deduct plan may pay pocket
prescript cover patient coinsur respons percent
research show high cost share associ lower medic adher increas abandon rate
pharmaceut research manufactur america phrma
acquisdata date busi intellig report cover develop world
report vast archiv corpor document list compani around world
